Trellus Management's Top Biotech Stock Picks For Q4
Trellus Management is a New York-based long/short equity hedge fund founded by Adam Usdan in 1994.
Synergy Pharmaceuticals Inc. (SGYP)
Market is closed
News
- First
- << Previous
- 21 - 30
- Next >>
5 Healthcare Stocks Under $10 Ready To Pop
Investing in the healthcare sector can be tricky, especially if you're looking for high returns and want to invest in clinical-stage companies, which represent an above-average risk.
Hedge Funds Were Right About Synergy Pharmaceuticals Inc (SGYP), Shares Soaring By The Minute, Up 65% Today
Shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP) are soaring by the minute today, currently up by 65% following the release of positive data from the biopharmaceutical company's late stage trial for...
Synergy Pharmaceuticals Inc (SGYP), Proteon Therapeutics Inc (PRTO): James E. Flynn and Peter Kolchinsky Think These Stocks Look Healthy
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and Proteon Therapeutics Inc (NASDAQ:PRTO) are in the spotlight as James E.
Here is What Hedge Funds Think About Dynavax Technologies Corporation (DVAX)
If you were to ask many market players, hedge funds are seen as useless, outdated financial vehicles of a forgotten age.
Depomed Inc (DEPO): Hedge Funds Are Bearish and Insiders Are Undecided, What Should You Do?
In the eyes of many market players, hedge funds are viewed as delayed, outdated financial vehicles of an era lost to time.
Should You Avoid Orexigen Therapeutics, Inc. (OREX)?
In the financial world, there are a multitude of metrics shareholders can use to watch their holdings. A couple of the most innovative are hedge fund and insider trading movement.
Hedge Funds Are Crazy About Dynavax Technologies Corporation (DVAX)
To the average investor, there are dozens of gauges shareholders can use to track publicly traded companies. A couple of the most useful are hedge fund and insider trading sentiment.
Depomed Inc (DEPO): Hedge Funds and Insiders Are Bullish, What Should You Do?
Depomed Inc (NASDAQ:DEPO) was in 13 hedge funds' portfolio at the end of the first quarter of 2013.
Orexigen Therapeutics, Inc. (OREX): Are Hedge Funds Right About This Stock?
To the average investor, there are plenty of methods shareholders can use to monitor their holdings. A pair of the most useful are hedge fund and insider trading interest.
- First
- << Previous
- 21 - 30
- Next >>
Billionaire Hedge Funds
